Clinical Trials Directory

Trials / Unknown

UnknownNCT05617651

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

Phase 1 Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T in Healthy Adult Volunteers Under Fed Condition

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Il-Yang Pharm. Co., Ltd. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

This study evaluate the pharmacokinetic and safety of IY-NT-T in healthy adults

Detailed description

Phase 1 study to evaluate the safety and the pharmacokinetics of IY-NT-T in healthy adult volunteers under fed condition

Conditions

Interventions

TypeNameDescription
DRUGIY-NT-TIlaprazole 20mg
DRUGIY-NT-RIlaprazole 10mg

Timeline

Start date
2024-11-30
Primary completion
2024-12-10
Completion
2025-12-30
First posted
2022-11-15
Last updated
2023-03-01

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05617651. Inclusion in this directory is not an endorsement.